|
Income Statement Get Income Statement for: View: Quarterly Data | Annual Data All numbers in thousands PERIOD ENDING 31-Dec-03 30-Sep-03 30-Jun-03 31-Mar-03 Total Revenue 60 52 111 48 Cost of Revenue 532 369 540 324 Gross Profit (472) (317) (429) (276) Operating Expenses Research Development 811 814 665 855 Selling General and Administrative 1,727 1,466 1,854 1,920 Non Recurring - - - - Others 39 37 35 34 Total Operating Expenses - - - - Operating Income or Loss (3,049) (2,635) (2,982) (3,085) Income from Continuing Operations Total Other Income/Expenses Net 253 223 123 174 Earnings Before Interest And Taxes (2,796) (2,412) (2,859) (2,911) Interest Expense 4,895 1,792 3,745 1,508 Income Before Tax (7,692) (4,204) (6,604) (4,419) Income Tax Expense (11) (11) (11) (11) Minority Interest 343 290 424 376 Net Income From Continuing Ops (7,338) (3,903) (6,169) (4,032) Non-recurring Events Discontinued Operations - - - - Extraordinary Items - - - - Effect Of Accounting Changes - - - - Other Items - - - - Net Income (7,338) (3,903) (6,169) (4,032) Preferred Stock And Other Adjustments (1) (1) (1) (1) Net Income Applicable To Common Shares ($7,338) ($3,904) ($6,170) ($4,033) |
|
| aus der Diskussion: | Viragen - aktueller Artikel im Science Magazin |
| Autor (Datum des Eintrages): | FBoggi (15.02.04 13:18:28) |
| Beitrag: | 101 von 128 (ID:12157769) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |